Navigation Links
Preview of oral presentations at the 1st IOF-ESCEO Pre-Clinical Symposium
Date:2/23/2011

Registrants to the largest European clinical and research bone meeting - the European Congress on Osteoporosis & Osteoarthritis (ECCEO11-IOF) from March 23-26, 2011 - will receive free registration to the 1st IOF-ESCEO Pre-Clinical Symposium from March 22-23.

The IOF-ESCEO Pre-Clinical Symposium showcases new research at the cutting edge of basic and translational bone science. It will feature:

  • Eight plenary lectures by speakers E. Wagner, J.-P. David, A. Teti, Ph. Clzardin, M. Kassem, P. Bianco, T. Schinke and G. Karsenty
  • Meet-the-Faculty sessions: How to write a grant, C. Cooper; How to write a manuscript, G. Karsenty; How to build up a lecture, E. Wagner; Women in academic careers, A. Teti
  • Twenty-eight selected oral presentations (7 hours!).

Here's a sneak preview of 10 of the 28 orals and speakers:

  • DLK1/FA1 regulates the early chondrogenesis during embryonic endochondral bone formation process and its expression is modulated by TGF-β1 signaling pathway - B. Abdallah

  • Genetic variation in the LRP4 gene influences bone mineral density and hip geometry while missense mutations cause sclerosteosis - E. Piters

  • Sclerostin antibody treatment enhances fracture healing and increases bone mass and strength in non-fractured bones in an adult rat closed femoral fracture model - H. Ke

  • Genome wide association study identifies seven loci that account for 86% of the population attributable risk of paget's disease of bone - O. Albagha

  • Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor - J. Tuckermann

  • MicroRNA-138 targets focal adhesion kinase and regulates In Vivo - M. Kassem

  • Control of bone resorption by semaphorin 4D is dependent on ovarian function - I. Machuca-Gayet

  • Iron overload stimulates osteoclast differentiation of murine osteoclast progenitor RAW 264.7 Through the production of reactive oxygen species - J. Peng

  • MHC class II transactivator: a novel regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity - S. Cenci

  • Strontium ranelate inhibits key factors affecting bone remodelling in human osteoarthritic subchondral bone osteoblasts - J. Martel-Pelletier

Visit http://www.ecceo11-iof.org/pre-clinical-symposium for the complete list of 28 oral presentations and 8 plenary lectures.

We look forward to seeing you in Valencia! www.ecceo11-iof.org


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Innerscope Research(R) Uses Same-Day Results From Biometric Study to Identify Key Themes, Styles Behind Effective, Engaging Speaker Presentations
2. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
3. Symposium to provide forum for best pre-clinical and translational bone research
4. A missing enzyme conveys major heart protection in pre-clinical work
5. Alzheimers disease therapeutic prevents long-term damage from TBI in pre-clinical studies
6. AAAS Symposium: New research facilitates scientific knowledge transfer
7. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
8. WidePoint Corporation Sponsors Identity Protection and Management Symposium, February 3, 2011
9. Oil spill symposium to convene scientists, media, policymakers and community leaders
10. Graduate physics students wins top honors in superconductivity symposium
11. Symposium marks milestones in honey bee management, research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
(Date:2/14/2017)... -- Wake Forest Baptist Medical Center today announced Julie Ann Freischlag, ... (CEO). Freischlag joins the medical center on May 1 ... who last year announced that he would transition to ... it since 2008.   As CEO, Freischlag ... academic health system, which includes Wake Forest School of ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Global Market for Bioproducts Should ... at a CAGR of 8.9%, This research ... into seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs ...
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today announced ... the sale of 12,835,490 shares of its common stock ... of companies. In connection with the sale of its common ... cash and issue to GlobeImmune 200,000 shares, an estimated ... "We are pleased to enter into this ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
(Date:3/23/2017)... March 23, 2017  Agriculture technology company Cool Planet ... and note conversion to commercialize its Cool Terra and ... on developing products that are simultaneously profitable as well ... the last 18 months. This latest round of funding ... Partners. The company,s primary product, Cool ...
Breaking Biology Technology: